Evotec SE (EVO) Divestments (2025 - 2026)
Evotec SE's (EVO) quarterly Divestments came in at -$4.5 million in Q1 2026, down 101.74% quarter-over-quarter from $259.3 million in Q4 2025.
Powered by 
Analysis
Evotec SE (EVO) Divestments (2025 - 2026) Analysis & Trends
Evotec SE has disclosed Divestments across 2 years of filings, most recently posting -$4.5 million for Q1 2026.
- In Q1 2026, Divestments changed N/A year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at $254.8 million (changed N/A YoY), while the FY2025 annual figure was $251.2 million, up 2117.6% from the prior year.
- Divestments came in at -$4.5 million for Q1 2026 at Evotec SE, down from $259.3 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $259.3 million in Q4 2025 to a low of -$4.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -14.88 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 116.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |